ID
15002
Beschrijving
This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ given at 12-18 mo of age to children primed with either pneumococcal vaccine or Prevenar™ in study 105553. Antibody persistence will be evaluated at 8-14 mo after completion of the 3-dose immunization course in study 105553. The immune response to a booster dose of GSK Biologicals' pneumococcal conjugate vaccine will also be evaluated when given at 12-18 mo to subjects not primed with GSK Biologicals' vaccine but with Prevenar™. The study has 3 groups. 1 group of children primed with GSK Biologicals' pneumococcal conjugate vaccine will receive a booster dose of the same vaccine. 2nd group of children primed with Prevenar™ will receive a booster dose of Prevenar™ (control group). 3rd group of children primed with Prevenar™ will receive a booster dose of GSK Biologicals' pneumococcal conjugate vaccine. All children will receive concomitantly a booster dose of DTPa-HBV-IPV/Hib vaccine. NCT00370396 Part: Non-Serious Adverse Events
Trefwoorden
Versies (3)
- 09-05-16 09-05-16 -
- 09-05-16 09-05-16 -
- 11-05-16 11-05-16 -
Geüploaded op
11 mei 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Non-Serious Adverse Events Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine NCT00370396
Non-Serious Adverse Events "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396
Beschrijving
Non Serious Adverse Events
Alias
- UMLS CUI-1
- C0877248
Beschrijving
Non Serious Adverse Events: List
Alias
- UMLS CUI-1
- C0877248
Beschrijving
AE No.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Description of Adverse Event
Datatype
text
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Site of Adverse Event
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1515974
Beschrijving
Start date
Datatype
date
Maateenheden
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0808070
Beschrijving
Stop Date
Datatype
date
Alias
- UMLS CUI [1]
- C0806020
Beschrijving
Start during immediate Post Vaccination Period
Datatype
boolean
Alias
- UMLS CUI [1]
- C0205253
Beschrijving
Maximum Intensity:
Datatype
integer
Alias
- UMLS CUI [1]
- C0518690
Beschrijving
Relationship to investigational products
Datatype
text
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C0877248
Beschrijving
Outcome
Datatype
integer
Alias
- UMLS CUI [1]
- C1705586
Beschrijving
(Refer to protocol for full definition.) If yes please specify type: HO: Hospitalisation ER: Emergency Room MD: Medical Personnel
Datatype
boolean
Alias
- UMLS CUI [1]
- C0545082
Beschrijving
Medically Attended visit Specification
Datatype
text
Alias
- UMLS CUI [1]
- C0018704
Similar models
Non-Serious Adverse Events "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396
C0805701 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])